Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument.
AGREE
Guideline
Ocular melanoma
Orphan disease
Practice guideline
Uveal melanoma
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
02
01
2020
accepted:
30
01
2020
pubmed:
10
2
2020
medline:
4
4
2020
entrez:
10
2
2020
Statut:
ppublish
Résumé
Clinical practice guidelines provide recommendations for the management of diseases. In orphan conditions such as uveal melanoma (UM), guideline developers are challenged to provide practical and useful guidance even in the absence of high-quality evidence. Here, we assessed the methodological quality and identified deficiencies of international guidelines on UM as a base for future guideline development. A systematic search was carried out in guideline databases, Medline and Embase until 27th May 2019 for guidelines on UM published between 2004 and 2019. Five independent reviewers assessed the methodological quality of the identified guidelines using the instruments "Appraisal of Guidelines for Research and Evaluation II" (AGREE II) and AGREE-REX (Recommendation EXcellence). Descriptive analysis was performed and subgroup differences were explored with the Kruskal-Wallis (H) test. The relationship between the individual domains and items of the instruments were examined using Spearman's correlation. Five guidelines published from 2014 to 2018 by consortia of the United States of America, Canada and the United Kingdom (UK) were included. The highest scores were obtained by the UK guideline fulfilling 48-86% of criteria in AGREE II and 30-60% for AGREE-REX. All guidelines showed deficiencies in the domains "editorial independence", "applicability", and "recommendation". Subgroup differences were identified only for the domain "editorial independence". The UK guideline achieved the highest scores with both instruments and may serve as a basis for future guideline development in UM. The domains "editorial independence", "recommendation", and "applicability" were identified as methodological weaknesses and require particular attention and improvement in future guidelines.
Identifiants
pubmed: 32036455
doi: 10.1007/s00432-020-03141-w
pii: 10.1007/s00432-020-03141-w
pmc: PMC7085474
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1079-1088Références
Agarwala SS, Eggermont AM, O'Day S, Zager JS (2014) Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer 120:781–789. https://doi.org/10.1002/cncr.28480
doi: 10.1002/cncr.28480
AGREE-REX Research Team (2019). The Appraisal of Guidelines Research & Evaluation—Recommendation EXcellence (AGREE-REX) [Electronic version]. https://www.agreetrust.org/wp-content/uploads/2019/04/AGREE-REX-2019.pdf . Accessed 18 Nov 2019
Barker CA, Salama AK (2018) New NCCN guidelines for uveal melanoma and treatment of recurrent or progressive distant metastatic melanoma. J Natl Compr Cancer Netw 16:646–650. https://doi.org/10.6004/jnccn.2018.0042
doi: 10.6004/jnccn.2018.0042
Bedikian AY (2006) Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin 46:151–166
doi: 10.1097/01.iio.0000195852.08453.de
Boffin N, Swinnen E, Wens J, Urbina M, Van der Heyden J, Van Casteren V (2018) General practice care for patients with rare diseases in Belgium A Cross-Sectional Survey. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph15061180
doi: 10.3390/ijerph15061180
pmcid: 6025074
pubmed: 6025074
Brouwers MC, Florez ID, McNair SA, Vella ET, Yao X (2019) Clinical practice guidelines: tools to support high quality patient care. Semin Nucl Med 49:145–152. https://doi.org/10.1053/j.semnuclmed.2018.11.001
doi: 10.1053/j.semnuclmed.2018.11.001
Chattopadhyay C et al (2016) Uveal melanoma: From diagnosis to treatment and the science in between. Cancer 122:2299–2312. https://doi.org/10.1002/cncr.29727
doi: 10.1002/cncr.29727
Dans AL, Dans LF (2010) Appraising a tool for guideline appraisal (the AGREE II instrument). J Clin Epidemiol 63:1281–1282. https://doi.org/10.1016/j.jclinepi.2010.06.005
doi: 10.1016/j.jclinepi.2010.06.005
Graham R, Mancher M, Wolman MD, Greenfield S, Steinberg E (2011) Clinical practice guidelines we can trust. National Academies Press, Washington DC. https://doi.org/10.17226/13058
doi: 10.17226/13058
Heppt MV et al (2017a) Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. Eur J Cancer 82:56–65. https://doi.org/10.1016/j.ejca.2017.05.038
doi: 10.1016/j.ejca.2017.05.038
Heppt MV et al (2017b) Immune checkpoint blockade for unresectable or metastatic uveal melanoma: a systematic review. Cancer Treat Rev 60:44–52. https://doi.org/10.1016/j.ctrv.2017.08.009
doi: 10.1016/j.ctrv.2017.08.009
Heppt MV et al (2019) Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study. J Immunother Cancer 7:299. https://doi.org/10.1186/s40425-019-0800-0
doi: 10.1186/s40425-019-0800-0
pmcid: 6854774
pubmed: 6854774
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
doi: 10.2307/2529310
Mallone S et al (2012) Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe. Eur J Cancer 48:1167–1175. https://doi.org/10.1016/j.ejca.2011.10.004
doi: 10.1016/j.ejca.2011.10.004
Mathis T et al (2018) Management of uveal melanomas, guidelines for oncologists. Bull Cancer 105:967–980. https://doi.org/10.1016/j.bulcan.2018.07.011
doi: 10.1016/j.bulcan.2018.07.011
Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT, American Brachytherapy S (2003) The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 56:544–555
doi: 10.1016/S0360-3016(03)00006-3
Nathan P et al (2015) Uveal melanoma UK national guidelines. Eur J Cancer 51:2404–2412. https://doi.org/10.1016/j.ejca.2015.07.013
doi: 10.1016/j.ejca.2015.07.013
National Cancer Institute (2019) Intraocular (Uveal) Melanoma treatment (PDQ®)–health professional version. https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq#_84 . Accessed 19 Nov 2019
National Comprehensive Cancer Network (NCCN) (2018) Clinical Practice Guidelines in Oncology Uveal Melanoma, Version I. 2018
National Institute for Health and Care Excellence (2019) IMCgp100 for treating metastatic uveal melanoma (ID1441). https://www.nice.org.uk/guidance/indevelopment/gid-ta10428 . Accessed 20 Nov 2019
Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW (2008) Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 49:5230–5234. https://doi.org/10.1167/iovs.08-2145
doi: 10.1167/iovs.08-2145
pmcid: 2634606
pubmed: 2634606
Leitlinienprogramm Onkologie (2019) (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Diagnostik, Therapie und Nachsorge des Melanoms, Langversion 3.2, 2019, AWMF Registernummer: 032/024OL, https://www.leitlinienprogramm-onkologie.de/leit-linien/melanom/ . Accessed 18 Nov 2019
Pai M et al (2019) Strategies for eliciting and synthesizing evidence for guidelines in rare diseases. BMC Med Res Methodol 19:67. https://doi.org/10.1186/s12874-019-0713-0
doi: 10.1186/s12874-019-0713-0
pmcid: 6437842
pubmed: 6437842
Pflugfelder A et al (2013) Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma". J Dtsch Dermatol Ges 11(Suppl 6):1–116. https://doi.org/10.1111/ddg.12113_suppl
doi: 10.1111/ddg.12113_suppl
Rico Iturrioz R, Gutierrez-Ibarluzea I, Asua Batarrita J, Navarro Puerto MA, Reyes Dominguez A, Marin Leon I, de la Blanca Briones EP (2004) Assessment of clinical practice guidelines evaluation. Scales and criteria. Rev Esp Salud Publica 78:457–467. https://doi.org/10.1590/s1135-57272004000400004
doi: 10.1590/s1135-57272004000400004
Scottish Intercollegiate Guidelines Network (SIGN) (2017). Cutaneous melanoma (SIGN publication no. 146). https://www.sign.ac.uk/assets/sign146.pdf . Accessed 20 Dec 2019
Shoushtari AN, Carvajal RD (2014) GNAQ and GNA11 mutations in uveal melanoma. Melanoma Res 24:525–534. https://doi.org/10.1097/CMR.0000000000000121
doi: 10.1097/CMR.0000000000000121
Simpson ER et al (2014) The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy 13:1–14. https://doi.org/10.1016/j.brachy.2013.11.008
doi: 10.1016/j.brachy.2013.11.008
Skalicky SE, Holt PE, Giblin M, Taylor S, Conway RM (2008) Australian cancer network clinical practice guidelines for the management of ocular and periocular melanoma: an evidence-based literature analysis. Clin Experiment Ophthalmol 36:646–658. https://doi.org/10.1111/j.1442-9071.2008.01815.x
doi: 10.1111/j.1442-9071.2008.01815.x
Steeb T, Wessely A, Ruzicka T, Heppt MV, Berking C (2018) How to MEK the best of uveal melanoma: a systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma. Eur J Cancer 103:41–51. https://doi.org/10.1016/j.ejca.2018.08.005
doi: 10.1016/j.ejca.2018.08.005
Swetter SM et al (2019) Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 80:208–250. https://doi.org/10.1016/j.jaad.2018.08.055
doi: 10.1016/j.jaad.2018.08.055
Van Raamsdonk CD et al (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457:599–602. https://doi.org/10.1038/nature07586
doi: 10.1038/nature07586
pmcid: 19078957
Van Raamsdonk CD et al (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363:2191–2199. https://doi.org/10.1056/NEJMoa1000584
doi: 10.1056/NEJMoa1000584
pmcid: 3107972
pubmed: 3107972
Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D (2005) A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care 17:235–242. https://doi.org/10.1093/intqhc/mzi027
doi: 10.1093/intqhc/mzi027
Weis E et al (2016) Management of uveal melanoma: a consensus-based provincial clinical practice guideline. Current Oncology 23:e57–64. https://doi.org/10.3747/co.23.2859
doi: 10.3747/co.23.2859
pmcid: 4754070
pubmed: 4754070
Zeng X et al (2015) The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 8:2–10. https://doi.org/10.1111/jebm.12141
doi: 10.1111/jebm.12141